AbbVie
Organization
AbbVie Inc. is an American biopharmaceutical company headquartered in North Chicago, Illinois. Spun off from Abbott Laboratories in 2013, the company specializes in researching, developing, and manufacturing specialty therapeutics and medical devices for a wide range of medical conditions.
7 episodes featuring AbbVie
Stock Movers
Netflix slips on weak guidance while Abbott and Eli Lilly surge
Understanding these market movements reveals where corporate giants are placing their long-term bets, from streaming growth limits to emerging biotech frontiers.
Jul 16, 2026 · 7 min
Stock Movers
Mixed earnings forecasts trigger sharp stock swings for major market players
The latest corporate earnings reports show that even positive guidance upgrades are failing to satisfy investors who are increasingly wary of future economic headwinds.
Jul 16, 2026 · 6 min
Stock Movers
AI fears sink Concentrix while lawmakers target Merck and AbbVie trials
Investors are grappling with the immediate financial impacts of AI disruption and the growing geopolitical risks of conducting pharmaceutical research in China.
Jun 30, 2026 · 6 min
Stock Movers
European stocks surge as AI demand and biotech breakthroughs shift capital
Understanding these stock movements reveals how global themes like AI infrastructure and biotech safety trials are reshaping European equity portfolios.
Jun 30, 2026 · 5 min
Stock Movers
European stocks surge as Abivax and Maersk upgrade market outlooks
Strong corporate earnings and clinical breakthroughs are boosting investor confidence in European biotech, logistics, and retail sectors.
Jun 30, 2026 · 7 min
Stock Movers
AbbVie targets Apogee in eleven billion dollar deal as Regenxbio advances
Major pharmaceutical acquisitions and shifting regulatory pathways are rapidly redefining valuations in the biotechnology sector.
Jun 22, 2026 · 6 min
Stock Movers
Acquisition rumors and major AI alliances spark pre-market stock surges
This episode highlights how strategic acquisitions and artificial intelligence partnerships are rapidly reshaping valuations in traditional and tech sectors alike.
Jun 22, 2026 · 6 min